Jan Grøndahl-Hansen

Title: Jan Grøndahl-Hansen: Innovator in Cancer Research

Introduction

Jan Grøndahl-Hansen is a notable inventor based in Holte, Denmark. He has made significant contributions to the field of cancer research, particularly in the area of tumor growth inhibition. His innovative approaches aim to improve therapeutic methods for treating malignancies.

Latest Patents

Jan Grøndahl-Hansen holds a patent related to the suppression of inhibitors. The patent, titled "Suppression of inhibitors," focuses on methods for inhibiting malignant tumor growth, invasion, and metastasis in patients. The method involves suppressing the inhibitory activity of a protease or a non-proteolytic matrix-degrading enzyme (IPNME) in malignant tumor tissue. This suppression can be achieved by administering compounds that interact with the IPNME or by targeting the transcription of genes encoding the IPNME. The invention also includes methods for selecting and identifying compounds for therapeutic use in treating malignancies. He has 1 patent to his name.

Career Highlights

Jan Grøndahl-Hansen is associated with Cancerforskningsfonden Af 1989, an organization dedicated to cancer research. His work has been instrumental in advancing the understanding of tumor biology and developing new treatment strategies.

Collaborations

Throughout his career, Jan has collaborated with notable colleagues, including John Rømer and Charles Pyke. These collaborations have further enriched his research and contributed to the development of innovative cancer therapies.

Conclusion

Jan Grøndahl-Hansen is a pioneering inventor whose work in cancer research has the potential to significantly impact the treatment of malignancies. His innovative methods for inhibiting tumor growth demonstrate the importance of continued research in this critical field.